Vol 14, No 1 (2018)
Guidelines / Expert consensus
Published online: 2018-02-28
Recommendations for assessment and management of pain in cancer patients
DOI: 10.5603/OCP.2018.0005
Oncol Clin Pract 2018;14(1):1-14.
Abstract
Not available
References
- Higginson IJ, Murtagh F. Cancer pain epidemiology. W: Bruera E, Portenoy RK (red.) Cancer Pain. Assessment and Management. Cambridge University Press. 2010; 3: 37–52.
- Breivik H, Cherny N, Collett B, et al. Cancer-related pain: a pan-European survey of prevalence, treatment, and patient attitudes. Ann Oncol. 2009; 20(8): 1420–1433.
- van den Beuken-van Everdingen MHJ, de Rijke JM, Kessels AG, et al. Prevalence of pain in patients with cancer: a systematic review of the past 40 years. Ann Oncol. 2007; 18(9): 1437–1449.
- Mercadante S, Radbruch L, Caraceni A, et al. Steering Committee of the European Association for Palliative Care (EAPC) Research Network. Episodic (breakthrough) pain: consensus conference of an expert working group of the European Association for Palliative Care. Cancer. 2002; 94(3): 832–839.
- Bennett M. Treatment of cancer pain. W : Tracey I. (red.). Pain 2012. Refresher courses 14th World Congress on Pain. IASP Press, Seattle. ; 2012: 301–316.
- Caraceni A, Hanks G, Kaasa S, et al. European Palliative Care Research Collaborative (EPCRC), European Association for Palliative Care (EAPC). Use of opioid analgesics in the treatment of cancer pain: evidence-based recommendations from the EAPC. Lancet Oncol. 2012; 13(2): e58–e68.
- Ripamonti CI, Santini D, Maranzano E, et al. ESMO Guidelines Working Group. Management of cancer pain: ESMO Clinical Practice Guidelines. Ann Oncol. 2012; 23 Suppl 7: vii139–vii154.
- World Health Organization. Cancer Pain Relief. : Geneva.
- Mercadante S. Pharmacological management of cancer pain. W: Mogil J. (red.). Pain 2010. An Updated Review. Refresher Course Syllabus. IASP Press, Seattle. ; 2010: 37–41.
- Kalso E. Clinical pharmacology of opioids in the treament of pain. W: Mogil J. (red.). Pain 2010 – An Updated Review. IASP Press, Seattle. ; 2010: 207–216.
- McPherson M. Opioid therapy for cancer pain. W: Tracey I. (red.). Pain 2012. Refresher courses 14th World Congress on Pain.McPherson M. ed. IASP Press, Seattle : 319–326.
- Hardy J, Nauck F. Opioids for cancer pain. W: Walsh D., Caraceni A., Fainsinger R. (red.) Palliative Medicine. Saunders Elsevier, Philadelphia. ; 2009: 1404–1411.
- Reid CM, Gooberman-Hill R, Hanks GW. Opioid analgesics for cancer pain: symptom control for the living or comfort for the dying? A qualitative study to investigate the factors influencing the decision to accept morphine for pain caused by cancer. Ann Oncol. 2008; 19(1): 44–48.
- Ahmedzai SH, Leppert W, Janecki M, et al. Long-term safety and efficacy of oxycodone/naloxone prolonged-release tablets in patients with moderate-to-severe chronic cancer pain. Support Care Cancer. 2015; 23(3): 823–830.
- Krajnik M, Wordliczek J, Dobrogowski J. Standardy leczenia bólu u chorego na nowotwór. Terapia 2010; 248–249. : 3–9.
- Finnerup NB, Attal N, Haroutounian S, et al. Pharmacotherapy for neuropathic pain in adults: a systematic review and meta-analysis. Lancet Neurol. 2015; 14(2): 162–173.
- Leppert W. Pain management in patients with cancer: focus on opioid analgesics. Curr Pain Headache Rep. 2011; 15(4): 271–279.
- Garg R, Joshi S, Mishra S, et al. Evidence based practice of chronic pain. Indian J Palliat Care. 2012; 18(3): 155–161.
- Bhatnagar S, Gupta M. Evidence-based Clinical Practice Guidelines for Interventional Pain Management in Cancer Pain. Indian J Palliat Care. 2015; 21(2): 137–147.
- Jarosz J, Kaczmarek Z, Kowalski DM. de Walden Gałuszko K, Wyrwicz LS. Postępowanie w bólach nowotworowych. W: Krzakowski M., Warzocha K. (red.). Zalecenia postępowania diagnostyczno-terapeutycznego w nowotworach złośliwych u dorosłych 2013 rok. Via Medica : 627–637.